Afghanistan vs Cote d'Ivoire: Cases started on MDR-TB treatment
Afghanistan
464
in 2024
Cote d'Ivoire
465
in 2024
Afghanistan rank
30th
Cote d'Ivoire rank
29th
Cases started on MDR-TB treatment over time
- Afghanistan
- Cote d'Ivoire
How they compare
Cote d'Ivoire currently reports 465 against 464 in Afghanistan, a difference of 1.
The two have swapped places 6 times across 16 shared years of data; in 2008 it was Cote d'Ivoire ahead.
Afghanistan ranks 30th and Cote d'Ivoire ranks 29th of 193 countries.
Across the 3 decades both report, Afghanistan averaged higher in 1 and Cote d'Ivoire in 2.
Head to head by decade
| Decade | Afghanistan | Cote d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 10 | 10 | Cote d'Ivoire |
| 2010s | 134.3 | 224.1 | 89.8 | Cote d'Ivoire |
| 2020s | 464.8 | 449.6 | 15.2 | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Afghanistan or Cote d'Ivoire?
- Cote d'Ivoire, at 465 against 464 in Afghanistan as of 2024.
- What is the difference in cases started on mdr-tb treatment between Afghanistan and Cote d'Ivoire?
- 1, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Afghanistan and Cote d'Ivoire?
- 16 years are reported by both, from 2008 to 2024.
- How do Afghanistan and Cote d'Ivoire rank globally for cases started on mdr-tb treatment?
- Afghanistan ranks 30th and Cote d'Ivoire ranks 29th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.